IMA Advisory Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.2K Hold
139
﹤0.01% 275
2025
Q4
$33.5K Hold
139
﹤0.01% 274
2025
Q3
$38K Buy
139
+48
+53% +$13.1K ﹤0.01% 259
2025
Q2
$23.5K Buy
91
+1
+1% +$239 ﹤0.01% 278
2025
Q1
$20.1K Buy
+90
New +$21K ﹤0.01% 281
2019
Q3
Sell
-26
Closed -$3K 286
2019
Q2
$3K Hold
26
﹤0.01% 263
2019
Q1
$3K Hold
26
﹤0.01% 256
2018
Q4
$3K Hold
26
﹤0.01% 282
2018
Q3
$3K Hold
26
﹤0.01% 285
2018
Q2
$3K Buy
+26
New +$2.63K ﹤0.01% 381

Other funds holding RMD

IMA Advisory Services's RMD Position: Q1 2026 in Review

IMA Advisory Services held its ResMed (RMD) position steady in Q1 2026 at 139 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

IMA Advisory Services first reported a position in RMD in Q2 2018 and has held it in 10 quarters since. The position peaked at $38K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • IMA Advisory Services held 139 shares of ResMed worth $31.2K as of Q1 2026.
  • IMA Advisory Services left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #275 holding.
  • IMA Advisory Services first reported a position in ResMed in Q2 2018 and has held it in 10 quarters since.
  • IMA Advisory Services's ResMed position peaked at $38K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.